{"disease":{"id":"pah","name":"pah"},"drugs":{"marketed":[{"drug_id":"sotatercept","indication_name":"pulmonary arterial hypertension (PAH, Group 1 pulmonary hypertension)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winrevair","generic_name":"SOTATERCEPT","company_name":"Merck Sharp Dohme","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":"1443","mechanism":"Winrevair works by binding to and inhibiting the activity of activin receptors, which play a role in the development of pulmonary arterial hypertension."},{"drug_id":"sotatercept","indication_name":"pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winrevair","generic_name":"SOTATERCEPT","company_name":"Merck Sharp Dohme","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":"1443","mechanism":"Winrevair works by binding to and inhibiting the activity of activin receptors, which play a role in the development of pulmonary arterial hypertension."},{"drug_id":"macitentan-and-tadalafil","indication_name":"Chronic treatment of PAH","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Macitentan and Tadalafil","company_name":"Humanis Saglık Anonim Sirketi","drug_phase":"marketed","molecular_target":"","drug_class":"Phosphodiesterase 5 Inhibitor [EPC]","quality_score":10,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01347216","title":"COMPERA / COMPERA-KIDS","phase":"","overall_status":"RECRUITING","enrollment_count":14000,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT07217522","title":"Rutgers University Study of the Genetics of Pulmonary Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT07082933","title":"Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT03626688","title":"A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":687,"lead_sponsor_name":"United Therapeutics","has_results":false},{"nct_id":"NCT06987097","title":"Ambrisentan for Early Low-Risk Pulmonary Arterial Hypertension","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":410,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT07086989","title":"Cardiovascular Risk in Children With Chronic Conditions Study","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Semmelweis University","has_results":false},{"nct_id":"NCT05388682","title":"Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Chinese Pulmonary Vascular Disease Research Group","has_results":false},{"nct_id":"NCT06609837","title":"30-Second Sit-to-Stand Test for Assessing Functional Capacity in Juvenile Idiopathic Arthritis","phase":"","overall_status":"COMPLETED","enrollment_count":197,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT04199169","title":"Safety and Immunogenicity of a Nipah Virus Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":192,"lead_sponsor_name":"Auro Vaccines LLC","has_results":false},{"nct_id":"NCT03904693","title":"Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Actelion","has_results":true},{"nct_id":"NCT07245680","title":"COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":186,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07013149","title":"The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":121,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT07314814","title":"Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Prof. Valérie Mc Lin","has_results":false},{"nct_id":"NCT06221813","title":"Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Public Health Vaccines LLC","has_results":false},{"nct_id":"NCT01421069","title":"Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT01867450","title":"Study of Lung Health Among Workers Exposed to Diesel Exhaust","phase":"","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05546125","title":"a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Pfizer Pharmaceuticals Ltd.","has_results":false},{"nct_id":"NCT07318597","title":"Phase 2 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":99,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05967299","title":"Study of Intravenous ZMA001 in Healthy Subjects","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT06897696","title":"Effect of Dexmedetomidine and Total Intravenous Anesthesia on Endothelial Damage-Related Biomarkers","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Firat University","has_results":false},{"nct_id":"NCT07266012","title":"Incorporating the Venous Excess Ultrasound Score (VExUS Score) Into Contemporary Haemodynamic Risk Assessment in Pulmonary Arterial Hypertension: The INVEXUS-PAH Study","phase":"","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT06973382","title":"Effects of Pulmonary Rehabilitation on Quality of Life and Health in Pulmonary Arterial Hypertension Patients","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":84,"lead_sponsor_name":"Beijing Chao Yang Hospital","has_results":false},{"nct_id":"NCT07457762","title":"AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hypertension?","phase":"NA","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT03449524","title":"PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":69,"lead_sponsor_name":"Complexa, Inc.","has_results":false},{"nct_id":"NCT05178901","title":"A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Public Health Vaccines LLC","has_results":false},{"nct_id":"NCT06454422","title":"Implementing the Wuqinxi on Patients With Pulmonary Arterial Hypertension","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT01086540","title":"Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06477640","title":"Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension","phase":"NA","overall_status":"RECRUITING","enrollment_count":55,"lead_sponsor_name":"University of Rochester","has_results":false},{"nct_id":"NCT06819059","title":"Safety and Effectiveness of a Virtual Pediatric Cardiac Rehabilitation Program or Telerehabilitation in Children With Heart Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT06753981","title":"Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study","phase":"","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT07232368","title":"The Effect of Slow-Paced Breathing on Patient Outcomes in Pulmonary Arterial Hypertension","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Ege University","has_results":false},{"nct_id":"NCT07498803","title":"Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Philipps University Marburg","has_results":false},{"nct_id":"NCT05398796","title":"Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT05332847","title":"Point of Care Ultrasonography Assessment During Pulmonary Hypertension Clinic","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Soroka University Medical Center","has_results":false},{"nct_id":"NCT04053543","title":"CXA-10 Study in Subjects With Pulmonary Arterial Hypertension","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":33,"lead_sponsor_name":"Complexa, Inc.","has_results":false},{"nct_id":"NCT02276872","title":"Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"United Therapeutics","has_results":true},{"nct_id":"NCT07177703","title":"Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":32,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT07356375","title":"Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral Selexipag in Pulmonary Arterial Hypertension","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":32,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT06553924","title":"Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Humanis Saglık Anonim Sirketi","has_results":false},{"nct_id":"NCT07487441","title":"Reverse Remodeling of the Pulmonary Vasculature: a Longitudinal, Investigational Study of the Effects of Sotatercept.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Franz Rischard, DO","has_results":false},{"nct_id":"NCT06553937","title":"Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Humanis Saglık Anonim Sirketi","has_results":false},{"nct_id":"NCT07453030","title":"Long-Term Outcomes of Selexipag in Schistosomiasis-Associated Pulmonary Arterial Hypertension","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Caio Júlio César dos Santos Fernandes","has_results":false},{"nct_id":"NCT03145298","title":"ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT05947240","title":"Effects of UE Aerobic Exercise on Exercise Capacity and PA in Patients With Pulmonary Arterial Hypertension.","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT07212322","title":"A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT04348708","title":"Long-Term Follow Up Study of Subjects Previously Administered HMI 102","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":21,"lead_sponsor_name":"Homology Medicines, Inc","has_results":false},{"nct_id":"NCT06658522","title":"Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT06917196","title":"PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.","phase":"","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT07357974","title":"Impact of Sotatercept on Pulmonary Artery and Right Ventricle Remodeling Imaging Assessed With 68Ga-FAPI PET/CT in Patients With PAH","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"University Hospital, Brest","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}